Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
98.5M
-
Shares change
-
+7.88M
-
Total reported value, excl. options
-
$2.31B
-
Value change
-
+$190M
-
Put/Call ratio
-
0.93
-
Number of buys
-
112
-
Number of sells
-
-60
-
Price
-
$23.50
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q4 2019
218 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q4 2019.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 98.5M shares
of 183M outstanding shares and own 53.73% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (12.4M shares), VANGUARD GROUP INC (7.86M shares), FMR LLC (6.58M shares), BAKER BROS. ADVISORS LP (6.02M shares), BlackRock Inc. (5.77M shares), TANG CAPITAL MANAGEMENT LLC (5.02M shares), JANUS HENDERSON GROUP PLC (4.92M shares), WELLINGTON MANAGEMENT GROUP LLP (4.5M shares), ArrowMark Colorado Holdings LLC (4.11M shares), and Clearbridge Investments, LLC (3.45M shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.